Back to top
more

The Ensign Group (ENSG)

(Delayed Data from NSDQ)

$141.37 USD

141.37
312,093

+1.19 (0.85%)

Updated Aug 15, 2024 04:00 PM ET

After-Market: $142.17 +0.80 (0.57%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 251)

Industry: Medical - Nursing Homes

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Here's Why Investors Should Hold Universal Health (UHS) Now

by Zacks Equity Research

Universal Health (UHS) benefits from growing patient volumes, sound segmental performance and a solid capital position.

Ensign Group (ENSG) Down 7.5% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Ensign Group (ENSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Factors That Make Ensign Group (ENSG) a Lucrative Bet Now

by Zacks Equity Research

Ensign Group (ENSG) is well-poised for growth on increasing service revenues, an expanding healthcare portfolio and a strong capital position.

Is The Ensign Group (ENSG) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Ensign Group (ENSG) is Poised for a Turnaround After Losing -7.68% in 4 Weeks

by Zacks Equity Research

Ensign Group (ENSG) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Should SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SLYG

Should SPDR Portfolio S&P 600 Small Cap ETF (SPSM) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SPSM

Ensign Group (ENSG) Beats on Q1 Earnings, Hikes '23 EPS View

by Zacks Equity Research

Ensign Group's (ENSG) first-quarter results benefit from growing skilled services revenues. Management estimates EPS of $4.64-$4.77 for this year, higher than the earlier mentioned $4.60-$4.74.

Ensign Group (ENSG) Q1 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Ensign Group (ENSG) delivered earnings and revenue surprises of 2.73% and 4.77%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Ensign Group (ENSG) is a Great Momentum Stock to Buy

by Zacks Equity Research

Does Ensign Group (ENSG) have what it takes to be a top stock pick for momentum investors? Let's find out.

UnitedHealth (UNH) Beats on Q1 Earnings, Ups EPS 2023 View

by Zacks Equity Research

Strong membership growth and consistent management of medical and operating costs aid UnitedHealth's (UNH) UnitedHealthcare unit in the first quarter.

Brookdale (BKD) Q1 Adjusted EBITDA to Beat View, Occupancy Up

by Zacks Equity Research

Brookdale Senior Living (BKD) witnesses 17 straight months of year-over-year increases in weighted average occupancy level.

Ensign Group (ENSG) Upgraded to Buy: Here's What You Should Know

by Zacks Equity Research

Ensign Group (ENSG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Should iShares Core S&P Small-Cap ETF (IJR) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for IJR

Here's Why Investors Should Hold Ensign Group (ENSG) Stock Now

by Zacks Equity Research

Ensign Group (ENSG) remains well-poised for growth on the back of a growing revenue base, continuous pursuit of acquisitions and commendable financial position.

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Zacks Equity Research

Sector ETF report for PSCH

Should iShares S&P Small-Cap 600 Growth ETF (IJT) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for IJT

Ensign Group (ENSG) is a Top-Ranked Value Stock: Should You Buy?

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Ensign Group's (ENSG) Buyout Consolidates Colorado Presence

by Zacks Equity Research

The Ensign Group (ENSG) buys two skilled nursing facilities in Colorado, aiming to expand its portfolio of nursing homes in the state.

Here's Why Ensign Group (ENSG) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Ensign Group (ENSG) Shares Down 2% Since Q4 Earnings Release

by Zacks Equity Research

Ensign Group's (ENSG) fourth-quarter results indicate higher skilled services revenue and improved occupancies, partly offset by the increased cost of services.

Ensign Group (ENSG) Matches Q4 Earnings Estimates

by Zacks Equity Research

Ensign Group (ENSG) delivered earnings and revenue surprises of 0% and 1.22%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?